Background illustration for clinical trials search

Paid Clinical Trials Rochester

Discover 999 paid clinical trials in Rochester, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: Rochester MN, Chicago IL, Detroit MI, Nashville TN,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06706076

Phase 1, Phase 2, Recruiting

COMPARE-VENT Feasibility Pilot Study

for
Respiration Failure, Cardio Vascular Disease,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07656259

Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Rochester MN, Burnsville MN, Edina MN, Maplewood MN,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Rochester MN, Evanston IL, Chicago IL, Kansas City KS,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase 3, Recruiting

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

for
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Location: Rochester MN, Detroit MI, Cincinnati OH, Nashville TN,
Sponsor: Innoventric LTD

Sex: All

Age: 18 - 70+

Code: NCT06212193

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Rochester MN, Waterloo IA, Duluth MN, Sioux Falls SD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Rochester MN, Minneapolis MN, Iowa City IA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase 1, Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: Rochester MN, Toronto, Winston-Salem NC, Charlotte NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

for
Biliary Tract Cancer
Location: Rochester MN, Niles IL, Chicago IL, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06467357

Phase 3, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Rochester MN, Milwaukee WI, Chicago IL, Kansas City MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Rochester MN, Cleveland OH, Tyler TX, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase 1, Phase 2, Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Rochester MN, Eau Claire WI, Zion IL, Niles IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

for
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor,
Location: Rochester MN, Iowa City IA, St Louis MO, Columbus OH,
Sponsor: RayzeBio, Inc.

Sex: All

Age: 18+

Code: NCT07165132

Phase 1, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Rochester MN, Burnsville MN, Sioux Falls SD, Yankton SD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Rochester MN, Sioux Falls SD, Chicago IL, Pierre SD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for
B-cell Non-Hodgkin Lymphoma
Location: Rochester MN, Franklin TN, New York NY, Jacksonville FL
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07123454

Phase 1, Phase 2, Recruiting

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

for
Autosomal Dominant Polycystic Kidney Disease
Location: Rochester MN, Lenexa KS, Baltimore MD, Jacksonville FL,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 65

Code: NCT07228364

Phase 1, Recruiting

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

for
Primary Membranous Nephropathy
Location: Rochester MN, Minneapolis MN, Houston TX, Loma Linda CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07157787

Phase 2, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Rochester MN, Fort Wayne IN, Winnipeg, Springfield MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Rochester MN, Zion IL, Omaha NE, St Louis MO,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting